Apimeds Pharmaceuticals' MindWave NILA Token to List on Pionex Exchange, Expanding Access Ahead of MindChain Migration

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its MindWave Innovations subsidiary will list the NILA token on the Pionex exchange on October 14, 2026, broadening international access to the token ahead of its planned migration to the MindChain Layer 2 network.

Chicago Metrowire Staff
••Technology
Apimeds Pharmaceuticals' MindWave NILA Token to List on Pionex Exchange, Expanding Access Ahead of MindChain Migration

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange on Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex's standard trading features and automated trading tools.

The listing expands international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications. MindWave has recently signed agreements to develop three dedicated networks — AQUAEChain, FlashChain and AssureChain — on MindChain. Following the network's launch, NILA is designed to support transaction fees, staking and network security, subject to applicable regulatory and technical requirements. To view the full press release, visit https://ibn.fm/Hv464.

The listing matters because it provides a regulated, publicly traded company with a direct gateway to global crypto markets. By making NILA tradable on Pionex, Apimeds Pharmaceuticals and MindWave Innovations are positioning the token for broader adoption and liquidity before the MindChain network goes live. This could accelerate the development of enterprise blockchain solutions and attract institutional interest in real-world asset tokenization and regulated financial services, areas that MindWave targets.

MindWave Innovations Inc. USA, a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), develops enterprise blockchain infrastructure, the MindChain Layer 2 network, and institutional platforms for regulated financial services, real-world asset tokenization and enterprise applications. The company's latest news and updates are available in its newsroom at https://ibn.fm/APUS.

MindWaveDAO, the community and ecosystem layer around MindChain, connects companies, builders, validators and token holders. NILA holders vote on its proposals, including which builders are funded, which programs launch and how ecosystem resources are allocated, and its Transparency Center publishes contributions, allocations and governance results. This governance structure aims to ensure that the ecosystem remains accountable and responsive to its participants.

The announcement was distributed through TechMediaWire, a specialized communications platform focused on pioneering public and private companies driving the future of technology. TechMediaWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries, along with article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions.

Blockchain Registration

QR Code for Blockchain Registration